Michael DePasquale - BIO-Key International Chairman, CEO and Pres

BKYI
 Stock
  

USD 0.93  0.07  7.00%   

  Chairman
Mr. Michael W. DePasquale serves as Chairman of the Board, Chief Executive Officer of BioKey International Inc. He served as CoChief Executive Officer of the Company from July 2005 to August 2006. Mr. DePasquale brings more than 27 years of executive management, sales and marketing experience to the Company. Prior to joining BIOkey, Mr. DePasquale served as the President and Chief Executive Officer of Prism eSolutions, Inc., a Pennsylvaniabased provider of professional consulting services and online solutions for ISO900114000 certification for customers in manufacturing, healthcare and government markets, since February 2001. From December 1999 through December 2000, Mr. DePasquale served as Group Vice President for WRC Media, a New Yorkbased distributor of supplemental education products and software. From January 1996 until December 1999, Mr. DePasquale served as Senior Vice President of Jostens Learning Corporationration, a Californiabased provider of multi media curriculum. Prior to Jostens, Mr. DePasquale held sales and marketing management positions with McGrawHill and Digital Equipment Corporationrationration
Age: 67  Chairman Since 2014      
732 359 1100  https://www.bio-key.com
DePasquale earned a BS degree from the New Jersey Institute of Technology.

Michael DePasquale Latest Insider Activity

Tracking and analyzing the buying and selling activities of Michael DePasquale against BIO-Key International stock is an integral part of due diligence when investing in BIO-Key International. Michael DePasquale insider activity provides valuable insight into whether BIO-Key International is net buyers or sellers over its current business cycle. Note, BIO-Key International insiders must abide by specific rules, including filing SEC forms every time they buy or sell BIO-Key International'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

BIO-Key International Management Efficiency

BIO-Key International has return on total asset (ROA) of (0.2422) % which means that it has lost $0.2422 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.4977) %, meaning that it created substantial loss on money invested by shareholders. BIO-Key International management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 715.87 K in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. BIO-Key International has a current ratio of 3.43, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist BIO-Key International until it has trouble settling it off, either with new capital or with free cash flow. So, BIO-Key International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BIO-Key International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BIO-Key to invest in growth at high rates of return. When we think about BIO-Key International's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 7 records

CHAIRMAN Since

Thomas StantonADTRAN Inc
2007
Carr BettisAudioEye
2015
Philip HeasleyACI Worldwide
2005
Art LevinsonApple Inc
2011
Rhea PosedelAehr Test Systems
2013
ChihHsiang LinApplied Opt
2014
Arthur LevinsonApple Inc
2011
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey. Bio-Key Intl operates under Security Protection Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people. BIO-Key International (BKYI) is traded on NASDAQ Exchange in USA and employs 51 people. BIO-Key International is listed under Systems Software category by Fama And French industry classification.

BIO-Key International Leadership Team

Elected by the shareholders, the BIO-Key International's board of directors comprises two types of representatives: BIO-Key International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BIO-Key. The board's role is to monitor BIO-Key International's management team and ensure that shareholders' interests are well served. BIO-Key International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BIO-Key International's outside directors are responsible for providing unbiased perspectives on the board's policies.
Scott Mahnken, VP of Marketing
Mark Cochran, Pres PortalGuard
Cecilia Welch, Chief Officer
Pieter Knook, Director
Akintunde Jeje, Managing Africa
Alex Rocha, Managing EMEA
Thomas Gilley, Director
Kwok Wong, MD ViceChairman
Michael DePasquale, Chairman, CEO and Pres
Frederick Corsentino, Chief Revenue Officer
Jianhui Yau, Director
James Sullivan, VP Officer
Thomas Bush, Director
Fabian Shin, Director
Robert Michel, Director
Mira LaCous, Chief Officer
Charles Romeo, Independent Director
John Schoenherr, Independent Director
Barbara Rivera, Director
Renat Zhdanov, Chief Scientist and VP

BIO-Key Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BIO-Key International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BIO-Key International in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BIO-Key International's short interest history, or implied volatility extrapolated from BIO-Key International options trading.

Pair Trading with BIO-Key International

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BIO-Key International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIO-Key International will appreciate offsetting losses from the drop in the long position's value.

Moving against BIO-Key International

-0.87LSCCLattice Semiconductor Tech BoostPairCorr
-0.77ADIAnalog Devices Tech BoostPairCorr
-0.77ASXASE Industrial Holding Tech BoostPairCorr
-0.69INFNInfinera Normal TradingPairCorr
The ability to find closely correlated positions to BIO-Key International could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BIO-Key International when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BIO-Key International - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BIO-Key International to buy it.
The correlation of BIO-Key International is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BIO-Key International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BIO-Key International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BIO-Key International can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for analysis

When running BIO-Key International price analysis, check to measure BIO-Key International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO-Key International is operating at the current time. Most of BIO-Key International's value examination focuses on studying past and present price action to predict the probability of BIO-Key International's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BIO-Key International's price. Additionally, you may evaluate how the addition of BIO-Key International to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Is BIO-Key International's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO-Key International. If investors know BIO-Key will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO-Key International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
8.2 M
Quarterly Revenue Growth YOY
0.058
Return On Assets
(0.24) 
Return On Equity
(0.50) 
The market value of BIO-Key International is measured differently than its book value, which is the value of BIO-Key that is recorded on the company's balance sheet. Investors also form their own opinion of BIO-Key International's value that differs from its market value or its book value, called intrinsic value, which is BIO-Key International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO-Key International's market value can be influenced by many factors that don't directly affect BIO-Key International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO-Key International's value and its price as these two are different measures arrived at by different means. Investors typically determine BIO-Key International value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO-Key International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.